Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Cystitis

2-amino-5-phosphonovalerate has been researched along with Cystitis in 2 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Cystitis: Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rice, ASC1
McMahon, SB1
Lecci, A1
Giuliani, S1
Santicioli, P1
Maggi, CA1

Other Studies

2 other studies available for 2-amino-5-phosphonovalerate and Cystitis

ArticleYear
Pre-emptive intrathecal administration of an NMDA receptor antagonist (AP-5) prevents hyper-reflexia in a model of persistent visceral pain.
    Pain, 1994, Volume: 57, Issue:3

    Topics: 2-Amino-5-phosphonovalerate; Animals; Chronic Disease; Cystitis; Differential Threshold; Dose-Respon

1994
Involvement of spinal tachykinin NK1 and NK2 receptors in detrusor hyperreflexia during chemical cystitis in anaesthetized rats.
    European journal of pharmacology, 1994, Jul-01, Volume: 259, Issue:2

    Topics: 2-Amino-5-phosphonovalerate; Animals; Benzamides; Cyclophosphamide; Cystitis; Indoles; Injections, I

1994